Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-nitrobenzenearsonic Acid
2. Nitarsone, Disodium Salt
3. Nitarsone, Monosodium Salt
4. P-nitrobenzenearsonic Acid
5. P-nitrophenylarsonic Acid
1. 98-72-6
2. Histostat
3. 4-nitrophenylarsonic Acid
4. (4-nitrophenyl)arsonic Acid
5. Nitarson
6. P-nitrobenzenearsonic Acid
7. 4-nitrobenzenearsonic Acid
8. P-nitrophenylarsonic Acid
9. Hep-a-stat
10. Histostat 50
11. Nitarsonum
12. (p-nitrophenyl)arsonic Acid
13. Arsonic Acid, (4-nitrophenyl)-
14. Arsonic Acid, 4-nitrophenyl
15. Nitarsone [usan:inn]
16. Ras-26
17. Histostat-50
18. Nsc 5085
19. Benzenearsonic Acid, P-nitro-
20. Jp2en8woru
21. Nitarsone (usan/inn)
22. Nsc-5085
23. Chebi:62629
24. Nsc5085
25. C6h6asno5
26. Ncgc00181154-01
27. 4-(hydroxy(oxido)amino)phenylarsonic Acid
28. Dsstox_cid_25007
29. Dsstox_rid_80648
30. Dsstox_gsid_45007
31. Nitarson [inn-spanish]
32. Nitarsonum [inn-latin]
33. Cas-98-72-6
34. Unii-jp2en8woru
35. Einecs 202-695-8
36. Brn 2939908
37. Nitarsone(usan)
38. Nitarsone [inn]
39. Nitarsone [mi]
40. Nitarsone, Inn, Usan
41. Nitarsone [usan]
42. P-nitro-benzenearsonic Acid
43. Wln: Wnr D-as-qqo
44. (4-nitrophenyl)-arsonic Acid
45. 4-o2c6h4aso3h2
46. Schembl636746
47. Nitarsone [green Book]
48. Chembl1721359
49. Dtxsid9045007
50. P-nitrobenzenearsonic Acid, 8ci
51. Hms3264a20
52. Pharmakon1600-01506182
53. Tox21_112758
54. Tox21_302274
55. Mfcd00024575
56. Nsc760413
57. Stk368450
58. Akos005444110
59. Tox21_112758_1
60. Ccg-213632
61. Db11437
62. Nsc-760413
63. Ncgc00181154-03
64. Ncgc00256021-01
65. Ac-20060
66. Db-057744
67. Ft-0631513
68. N0964
69. Sw219750-1
70. Nitarsone, Vetranal(tm), Analytical Standard
71. D05175
72. T73111
73. Ab01563154_01
74. Ab01563154_02
75. Sr-01000883940
76. Sr-01000883940-1
77. W-100066
78. Q15425773
| Molecular Weight | 247.04 g/mol |
|---|---|
| Molecular Formula | C6H6AsNO5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 1 |
| Exact Mass | 246.946192 g/mol |
| Monoisotopic Mass | 246.946192 g/mol |
| Topological Polar Surface Area | 103 Ų |
| Heavy Atom Count | 13 |
| Formal Charge | 0 |
| Complexity | 236 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Nitarsone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nitarsone, including repackagers and relabelers. The FDA regulates Nitarsone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nitarsone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Nitarsone supplier is an individual or a company that provides Nitarsone active pharmaceutical ingredient (API) or Nitarsone finished formulations upon request. The Nitarsone suppliers may include Nitarsone API manufacturers, exporters, distributors and traders.
Nitarsone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nitarsone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nitarsone GMP manufacturer or Nitarsone GMP API supplier for your needs.
A Nitarsone CoA (Certificate of Analysis) is a formal document that attests to Nitarsone's compliance with Nitarsone specifications and serves as a tool for batch-level quality control.
Nitarsone CoA mostly includes findings from lab analyses of a specific batch. For each Nitarsone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nitarsone may be tested according to a variety of international standards, such as European Pharmacopoeia (Nitarsone EP), Nitarsone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nitarsone USP).
LOOKING FOR A SUPPLIER?
